Hirsch Lab
@HirschLab
Followers
758
Following
96
Media
15
Statuses
253
Latest news from Drug Design and Optimization at @Helmholtz_HIPS led by Prof. Dr. Anna K.H. Hirsch @Saar_Uni Account run by PhD students.
Saarbrücken, Germany
Joined May 2020
RT @ElgaherWalid: We are looking for excellent candidates for three PD positions at the Department of Drug Design and Optimization, HIPS. Y….
0
4
0
We are seeking excellent candidates for three PostDoc positions at the Department of Drug Design and Optimization, HIPS. If you have a strong background in MedChem and synthesis of bioactive small molecules, then feel free to apply!.
2
28
61
RT @ChemMedChem: Exploring the Translational Gap of a Novel Class of Escherichia coli IspE Inhibitors (A. K. H. Hirsch et al.) @HirschLab #….
chemistry-europe.onlinelibrary.wiley.com
Challenges in the discovery of selective IspE inhibitors with antibacterial activity and no toxicity: This work sheds light on the molecular properties for balancing enzymatic target and bacterial...
0
5
0
RT @ChemMedChem: #OnTheCover Front Cover: Exploring the Translational Gap of a Novel Class of Escherichia coli IspE Inhibitors (ChemMedChem….
0
3
0
🎉🔬🌟 Thrilled to announce our research hitting the cover of @ChemMedChem! 📰 Our article delves into the "Translational Gap of Escherichia coli IspE Inhibitors". Read it here :
chemistry-europe.onlinelibrary.wiley.com
Challenges in the discovery of selective IspE inhibitors with antibacterial activity and no toxicity: This work sheds light on the molecular properties for balancing enzymatic target and bacterial...
0
4
21
🎉 Exciting news! 📚🔬 Our group's new publication on "Inhibitors of Elastase LasB for Pseudomonas aeruginosa Lung Infections" is out now! 💡🦠 Offering promising avenues for treating this critical health concern.
pubs.acs.org
Infections caused by the Gram-negative pathogen Pseudomonas aeruginosa are emerging worldwide as a major threat to human health. Conventional antibiotic monotherapy suffers from rapid resistance...
0
4
30
Check out our new publication! : Exploring the translational gap of a novel class of Escherichia coli IspE inhibitors (.
chemistry-europe.onlinelibrary.wiley.com
Challenges in the discovery of selective IspE inhibitors with antibacterial activity and no toxicity: This work sheds light on the molecular properties for balancing enzymatic target and bacterial...
0
0
7
RT @NatRevDrugDisc: Artificial intelligence for natural product drug discovery .A review by a team including @marni….
0
61
0
Our own @GwenalleJZQUEL1 presented her work on LasB inhibitors at the @GDCh_aktuell Frontiers in Medicinal Chemistry in Vienna this past week!
0
0
12
Congratulations to Prof. Rolf Hartmann for winning the Friedrich Stolz Award at the @GDCh_aktuell Frontiers in Medicinal Chemistry conference in Vienna!.
0
3
11
Congratulations to our own @AlaaAlhayek9 for winning the @GDCh_aktuell PhD Prize Award presented at the Frontiers in Medicinal Chemistry conference in Vienna!.
1
2
11
RT @OpsenicaLab: Best of luck to our brilliant colleagues who are embarking on their postdoc journeys in different corners of the world! @R….
0
3
0
RT @Helmholtz_HIPS: Looking for a PhD position in microbiome reseach? 👩🔬🧑🔬. Together with @Saar_Uni we are launching the EU-funded grad s….
0
12
0
RT @Helmholtz_HZI: Bei der Helmholtz Drug Discovery Conference 2023 #HDDC2023 am 15./16.5.2023 diskutieren Expert:innen die Herausforderung….
0
3
0
Anna Hirsch .@HirschLab. is co-organising the Frontiers in Medicinal Chemistry Conference, for which registration is now open:.
0
4
8
RT @Helmholtz_HIPS: Die Wissenschaftlerin Mariia Nesterkina musste aus der Ukraine flüchten, konnte ihre Forschung aber in der Abteilung vo….
tagesschau.de
Gen-Technik, Medizin, Archäologie, Psychologie oder Kunstgeschichte – neueste Studien und aktuelle Nachrichten aus allen wissenschaftlichen Bereichen.
0
3
0
RT @antibioticsmdpi: 🆕#Review.The Structures and Binding Modes of Small-#Molecule #Inhibitors of #Pseudomonas aeruginosa Elastase LasB by D….
0
1
0
Our paper ( was selected as an Editor's Choice article: The Structures and Binding Modes of Small-Molecule Inhibitors of Pseudomonas aeruginosa Elastase LasB! #editorschoice.
mdpi.com
Elastase B (LasB) is a zinc metalloprotease and a crucial virulence factor of Pseudomonas aeruginosa. As the need for new strategies to fight antimicrobial resistance (AMR) constantly rises, this...
1
1
13
RT @antibioticsmdpi: #editorchoice.The Structures and Binding Modes of Small-#Molecule Inhibitors of #Pseudomonas #aeruginosa Elastase LasB….
0
1
0